Breast cancer is a political issue.
From funding for breast cancer research to drug approval to insurance regulation and beyond, the administration, Congress and state legislatures pass laws and develop regulations that affect all aspects of breast cancer research and care.
The majority of funding for breast cancer research outside of pharmaceutical companies comes through the federal government. A federal agency, the Food and Drug Administration (FDA), approves new drugs for breast cancer. Reform and regulation of the insurance industry happen through federal and state agencies.
NBCC seeks the commitment of our government—at all levels—to support meaningful research, expand access to quality health care, and adopt policies and laws that are backed by science and evidence. Then, together, we can end breast cancer forever.
Since its inception, the National Breast Cancer Coalition (NBCC) has set a legislative and public policy agenda that moves us closer to our mission to end breast cancer.
11/10/20Today, the Supreme Court heard oral arguments on a legal challenge supported by the Trump administration that seeks to overturn the Affordable Care Act (ACA). If the Court decides to overturn the ACA, that decision will impose significant negative impacts on the health care system generally and impose undue harm on National Breast Cancer Coalition (NBCC) members and those living with and at risk of breast cancer.
NBCC is proud of its legislative accomplishments. The following examples are just a few highlights: